Market Outlook
The Saudi Arabia Healthcare Bioconvergence Market was valued at USD 550.33 million in 2024 and is projected to reach USD 1,148.20 million by 2030, reflecting a robust CAGR of 4.42% during the forecast period. This growth is driven by the Kingdom’s Vision 2030 initiative, which emphasizes healthcare innovation and diversification from oil dependency. Government investments in advanced medical technologies, such as bioelectronics and precision medicine, are fostering a conducive e